Drug Modeling Softwares Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drug Modeling Softwares
1.2 Key Market Segments
1.2.1 Drug Modeling Softwares Segment by Type
1.2.2 Drug Modeling Softwares Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Drug Modeling Softwares Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Drug Modeling Softwares Market Competitive Landscape
3.1 Global Drug Modeling Softwares Revenue Market Share by Company (2019-2024)
3.2 Drug Modeling Softwares Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Drug Modeling Softwares Market Size Sites, Area Served, Product Type
3.4 Drug Modeling Softwares Market Competitive Situation and Trends
3.4.1 Drug Modeling Softwares Market Concentration Rate
3.4.2 Global 5 and 10 Largest Drug Modeling Softwares Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Drug Modeling Softwares Value Chain Analysis
4.1 Drug Modeling Softwares Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Drug Modeling Softwares Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Drug Modeling Softwares Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Modeling Softwares Market Size Market Share by Type (2019-2024)
6.3 Global Drug Modeling Softwares Market Size Growth Rate by Type (2019-2024)
7 Drug Modeling Softwares Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Modeling Softwares Market Size (M USD) by Application (2019-2024)
7.3 Global Drug Modeling Softwares Market Size Growth Rate by Application (2019-2024)
8 Drug Modeling Softwares Market Segmentation by Region
8.1 Global Drug Modeling Softwares Market Size by Region
8.1.1 Global Drug Modeling Softwares Market Size by Region
8.1.2 Global Drug Modeling Softwares Market Size Market Share by Region
8.2 North America
8.2.1 North America Drug Modeling Softwares Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Modeling Softwares Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Modeling Softwares Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Modeling Softwares Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Modeling Softwares Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 JSR Corporation(Crown Bioscience)
9.1.1 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Basic Information
9.1.2 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Product Overview
9.1.3 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Product Market Performance
9.1.4 JSR Corporation(Crown Bioscience) Drug Modeling Softwares SWOT Analysis
9.1.5 JSR Corporation(Crown Bioscience) Business Overview
9.1.6 JSR Corporation(Crown Bioscience) Recent Developments
9.2 Chemical Computing Group ULC
9.2.1 Chemical Computing Group ULC Drug Modeling Softwares Basic Information
9.2.2 Chemical Computing Group ULC Drug Modeling Softwares Product Overview
9.2.3 Chemical Computing Group ULC Drug Modeling Softwares Product Market Performance
9.2.4 JSR Corporation(Crown Bioscience) Drug Modeling Softwares SWOT Analysis
9.2.5 Chemical Computing Group ULC Business Overview
9.2.6 Chemical Computing Group ULC Recent Developments
9.3 Nimbus Therapeutics
9.3.1 Nimbus Therapeutics Drug Modeling Softwares Basic Information
9.3.2 Nimbus Therapeutics Drug Modeling Softwares Product Overview
9.3.3 Nimbus Therapeutics Drug Modeling Softwares Product Market Performance
9.3.4 JSR Corporation(Crown Bioscience) Drug Modeling Softwares SWOT Analysis
9.3.5 Nimbus Therapeutics Business Overview
9.3.6 Nimbus Therapeutics Recent Developments
9.4 Schrodinger, Inc
9.4.1 Schrodinger, Inc Drug Modeling Softwares Basic Information
9.4.2 Schrodinger, Inc Drug Modeling Softwares Product Overview
9.4.3 Schrodinger, Inc Drug Modeling Softwares Product Market Performance
9.4.4 Schrodinger, Inc Business Overview
9.4.5 Schrodinger, Inc Recent Developments
9.5 Genedata AG
9.5.1 Genedata AG Drug Modeling Softwares Basic Information
9.5.2 Genedata AG Drug Modeling Softwares Product Overview
9.5.3 Genedata AG Drug Modeling Softwares Product Market Performance
9.5.4 Genedata AG Business Overview
9.5.5 Genedata AG Recent Developments
9.6 Biognos AB
9.6.1 Biognos AB Drug Modeling Softwares Basic Information
9.6.2 Biognos AB Drug Modeling Softwares Product Overview
9.6.3 Biognos AB Drug Modeling Softwares Product Market Performance
9.6.4 Biognos AB Business Overview
9.6.5 Biognos AB Recent Developments
9.7 Compugen Ltd
9.7.1 Compugen Ltd Drug Modeling Softwares Basic Information
9.7.2 Compugen Ltd Drug Modeling Softwares Product Overview
9.7.3 Compugen Ltd Drug Modeling Softwares Product Market Performance
9.7.4 Compugen Ltd Business Overview
9.7.5 Compugen Ltd Recent Developments
9.8 Dassault Systemes
9.8.1 Dassault Systemes Drug Modeling Softwares Basic Information
9.8.2 Dassault Systemes Drug Modeling Softwares Product Overview
9.8.3 Dassault Systemes Drug Modeling Softwares Product Market Performance
9.8.4 Dassault Systemes Business Overview
9.8.5 Dassault Systemes Recent Developments
9.9 Acellera
9.9.1 Acellera Drug Modeling Softwares Basic Information
9.9.2 Acellera Drug Modeling Softwares Product Overview
9.9.3 Acellera Drug Modeling Softwares Product Market Performance
9.9.4 Acellera Business Overview
9.9.5 Acellera Recent Developments
9.10 Instem(Leadscope)
9.10.1 Instem(Leadscope) Drug Modeling Softwares Basic Information
9.10.2 Instem(Leadscope) Drug Modeling Softwares Product Overview
9.10.3 Instem(Leadscope) Drug Modeling Softwares Product Market Performance
9.10.4 Instem(Leadscope) Business Overview
9.10.5 Instem(Leadscope) Recent Developments
10 Drug Modeling Softwares Regional Market Forecast
10.1 Global Drug Modeling Softwares Market Size Forecast
10.2 Global Drug Modeling Softwares Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Modeling Softwares Market Size Forecast by Country
10.2.3 Asia Pacific Drug Modeling Softwares Market Size Forecast by Region
10.2.4 South America Drug Modeling Softwares Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug Modeling Softwares by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Drug Modeling Softwares Market Forecast by Type (2025-2030)
11.2 Global Drug Modeling Softwares Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Modeling Softwares Market Size Comparison by Region (M USD)
Table 5. Global Drug Modeling Softwares Revenue (M USD) by Company (2019-2024)
Table 6. Global Drug Modeling Softwares Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Modeling Softwares as of 2022)
Table 8. Company Drug Modeling Softwares Market Size Sites and Area Served
Table 9. Company Drug Modeling Softwares Product Type
Table 10. Global Drug Modeling Softwares Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Drug Modeling Softwares
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Modeling Softwares Market Challenges
Table 18. Global Drug Modeling Softwares Market Size by Type (M USD)
Table 19. Global Drug Modeling Softwares Market Size (M USD) by Type (2019-2024)
Table 20. Global Drug Modeling Softwares Market Size Share by Type (2019-2024)
Table 21. Global Drug Modeling Softwares Market Size Growth Rate by Type (2019-2024)
Table 22. Global Drug Modeling Softwares Market Size by Application
Table 23. Global Drug Modeling Softwares Market Size by Application (2019-2024) & (M USD)
Table 24. Global Drug Modeling Softwares Market Share by Application (2019-2024)
Table 25. Global Drug Modeling Softwares Market Size Growth Rate by Application (2019-2024)
Table 26. Global Drug Modeling Softwares Market Size by Region (2019-2024) & (M USD)
Table 27. Global Drug Modeling Softwares Market Size Market Share by Region (2019-2024)
Table 28. North America Drug Modeling Softwares Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Drug Modeling Softwares Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Drug Modeling Softwares Market Size by Region (2019-2024) & (M USD)
Table 31. South America Drug Modeling Softwares Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Drug Modeling Softwares Market Size by Region (2019-2024) & (M USD)
Table 33. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Basic Information
Table 34. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Product Overview
Table 35. JSR Corporation(Crown Bioscience) Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 36. JSR Corporation(Crown Bioscience) Drug Modeling Softwares SWOT Analysis
Table 37. JSR Corporation(Crown Bioscience) Business Overview
Table 38. JSR Corporation(Crown Bioscience) Recent Developments
Table 39. Chemical Computing Group ULC Drug Modeling Softwares Basic Information
Table 40. Chemical Computing Group ULC Drug Modeling Softwares Product Overview
Table 41. Chemical Computing Group ULC Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 42. JSR Corporation(Crown Bioscience) Drug Modeling Softwares SWOT Analysis
Table 43. Chemical Computing Group ULC Business Overview
Table 44. Chemical Computing Group ULC Recent Developments
Table 45. Nimbus Therapeutics Drug Modeling Softwares Basic Information
Table 46. Nimbus Therapeutics Drug Modeling Softwares Product Overview
Table 47. Nimbus Therapeutics Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 48. JSR Corporation(Crown Bioscience) Drug Modeling Softwares SWOT Analysis
Table 49. Nimbus Therapeutics Business Overview
Table 50. Nimbus Therapeutics Recent Developments
Table 51. Schrodinger, Inc Drug Modeling Softwares Basic Information
Table 52. Schrodinger, Inc Drug Modeling Softwares Product Overview
Table 53. Schrodinger, Inc Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Schrodinger, Inc Business Overview
Table 55. Schrodinger, Inc Recent Developments
Table 56. Genedata AG Drug Modeling Softwares Basic Information
Table 57. Genedata AG Drug Modeling Softwares Product Overview
Table 58. Genedata AG Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Genedata AG Business Overview
Table 60. Genedata AG Recent Developments
Table 61. Biognos AB Drug Modeling Softwares Basic Information
Table 62. Biognos AB Drug Modeling Softwares Product Overview
Table 63. Biognos AB Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Biognos AB Business Overview
Table 65. Biognos AB Recent Developments
Table 66. Compugen Ltd Drug Modeling Softwares Basic Information
Table 67. Compugen Ltd Drug Modeling Softwares Product Overview
Table 68. Compugen Ltd Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Compugen Ltd Business Overview
Table 70. Compugen Ltd Recent Developments
Table 71. Dassault Systemes Drug Modeling Softwares Basic Information
Table 72. Dassault Systemes Drug Modeling Softwares Product Overview
Table 73. Dassault Systemes Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Dassault Systemes Business Overview
Table 75. Dassault Systemes Recent Developments
Table 76. Acellera Drug Modeling Softwares Basic Information
Table 77. Acellera Drug Modeling Softwares Product Overview
Table 78. Acellera Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Acellera Business Overview
Table 80. Acellera Recent Developments
Table 81. Instem(Leadscope) Drug Modeling Softwares Basic Information
Table 82. Instem(Leadscope) Drug Modeling Softwares Product Overview
Table 83. Instem(Leadscope) Drug Modeling Softwares Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Instem(Leadscope) Business Overview
Table 85. Instem(Leadscope) Recent Developments
Table 86. Global Drug Modeling Softwares Market Size Forecast by Region (2025-2030) & (M USD)
Table 87. North America Drug Modeling Softwares Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Europe Drug Modeling Softwares Market Size Forecast by Country (2025-2030) & (M USD)
Table 89. Asia Pacific Drug Modeling Softwares Market Size Forecast by Region (2025-2030) & (M USD)
Table 90. South America Drug Modeling Softwares Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Drug Modeling Softwares Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Global Drug Modeling Softwares Market Size Forecast by Type (2025-2030) & (M USD)
Table 93. Global Drug Modeling Softwares Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Industrial Chain of Drug Modeling Softwares
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Modeling Softwares Market Size (M USD), 2019-2030
Figure 5. Global Drug Modeling Softwares Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Modeling Softwares Market Size by Country (M USD)
Figure 10. Global Drug Modeling Softwares Revenue Share by Company in 2023
Figure 11. Drug Modeling Softwares Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Drug Modeling Softwares Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Drug Modeling Softwares Market Share by Type
Figure 15. Market Size Share of Drug Modeling Softwares by Type (2019-2024)
Figure 16. Market Size Market Share of Drug Modeling Softwares by Type in 2022
Figure 17. Global Drug Modeling Softwares Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Drug Modeling Softwares Market Share by Application
Figure 20. Global Drug Modeling Softwares Market Share by Application (2019-2024)
Figure 21. Global Drug Modeling Softwares Market Share by Application in 2022
Figure 22. Global Drug Modeling Softwares Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Drug Modeling Softwares Market Size Market Share by Region (2019-2024)
Figure 24. North America Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Drug Modeling Softwares Market Size Market Share by Country in 2023
Figure 26. U.S. Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Drug Modeling Softwares Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Drug Modeling Softwares Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Drug Modeling Softwares Market Size Market Share by Country in 2023
Figure 31. Germany Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Drug Modeling Softwares Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Drug Modeling Softwares Market Size Market Share by Region in 2023
Figure 38. China Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Drug Modeling Softwares Market Size and Growth Rate (M USD)
Figure 44. South America Drug Modeling Softwares Market Size Market Share by Country in 2023
Figure 45. Brazil Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Drug Modeling Softwares Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Drug Modeling Softwares Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Drug Modeling Softwares Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Drug Modeling Softwares Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Drug Modeling Softwares Market Share Forecast by Type (2025-2030)
Figure 57. Global Drug Modeling Softwares Market Share Forecast by Application (2025-2030)
Industry Market Size
